Insider Trading & Ownership - Sandercock Colin

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Sandercock Colin
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2020-08-05
Sale(A)
2020-08-10
4:03 pm
Cue Biopharma Inc.CUESandercock Colin
SVP, General Counsel and Sec
13,374$20$267,480147,125
(Direct)
View
2020-08-05
Sale
2020-08-07
5:44 pm
Cue Biopharma Inc.CUESandercock Colin
SVP, General Counsel and Sec
13,274$20$265,480147,225
(Direct)
View
2020-08-03
Sale
2020-08-05
4:51 pm
Cue Biopharma Inc.CUESandercock Colin
SVP, General Counsel and Sec
6,626$20$132,530304,074
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-06-05
Option Award
2024-06-07
4:00 pm
N/A
2034-06-04
Cue Biopharma Inc.CUESandercock Colin
SVP, GENERAL COUNSEL
60,000$060,000
(Direct)
View
2024-03-06
Option Award
2024-03-08
4:00 pm
N/A
2034-03-05
Cue Biopharma Inc.CUESandercock Colin
SVP, GENERAL COUNSEL
175,000$0175,000
(Direct)
View
2023-07-21
Option Award
2023-07-25
12:27 pm
N/A
2033-07-20
Cue Biopharma Inc.CUESandercock Colin
SVP, GENERAL COUNSEL
75,000$075,000
(Direct)
View
2023-02-16
Option Award
2023-02-21
5:00 pm
N/A
2033-02-15
Cue Biopharma Inc.CUESandercock Colin
SVP, GENERAL COUNSEL
100,000$0100,000
(Direct)
View
2022-02-09
Option Award
2022-03-29
4:13 pm
N/A
2032-02-08
Cue Biopharma Inc.CUESandercock Colin
SVP, GENERAL COUNSEL
76,667$076,667
(Direct)
View
2021-02-10
Option Award
2021-02-12
5:43 pm
N/A
2031-02-09
Cue Biopharma Inc.CUESandercock Colin
SVP, General Counsel and Sec
50,000$050,000
(Direct)
View
2020-08-05
Exercise(A)
2020-08-10
4:03 pm
N/A
N/A
Cue Biopharma Inc.CUESandercock Colin
SVP, General Counsel and Sec
13,374$7.5147,125
(Direct)
View
2020-08-05
Exercise(A)
2020-08-10
4:03 pm
N/A
2024-12-27
Cue Biopharma Inc.CUESandercock Colin
SVP, General Counsel and Sec
13,374$0147,125
(Direct)
View
2020-08-05
Exercise
2020-08-07
5:44 pm
N/A
N/A
Cue Biopharma Inc.CUESandercock Colin
SVP, General Counsel and Sec
13,274$7.5147,225
(Direct)
View
2020-08-05
Exercise
2020-08-07
5:44 pm
N/A
2024-12-27
Cue Biopharma Inc.CUESandercock Colin
SVP, General Counsel and Sec
13,274$0147,225
(Direct)
View
2020-08-03
Exercise
2020-08-05
4:51 pm
N/A
N/A
Cue Biopharma Inc.CUESandercock Colin
SVP, General Counsel and Sec
6,626$7.5304,074
(Direct)
View
2020-08-03
Exercise
2020-08-05
4:51 pm
N/A
2024-12-27
Cue Biopharma Inc.CUESandercock Colin
SVP, General Counsel and Sec
6,626$0304,074
(Direct)
View
2020-02-05
Option Award
2020-02-12
4:53 pm
N/A
2030-02-05
Cue Biopharma Inc.CUESandercock Colin
SVP, General Counsel and Sec
20,000$020,000
(Direct)
View
(A) Indicate amendment filing.